Florian Kleinbeck is Director of Biocatalysis at Novartis in Basel (Switzerland). Following a PhD in natural product synthesis at ETH Zurich (Switzerland) and a postdoc in asymmetric catalysis at UC Berkeley(USA), he joined Novartis in Chemical & Analytical Development. Since his start, he contributed as
process chemist and project leader to late phase development projects and transfers into production for both small molecule and oligonucleotide projects. In addition, he extensively supported technical lifecycle management activities of established brands. In early 2024, he took on the role as team lead of the
Biocatalysis Team in Chemical & Analytical Development at Novartis.

Presentation Title: Early Phase to Full Scale Manufacturing. An Overview of Biocatalysis at Novartis Pharma

View company profile